Donna Lee D'antuono, RN in Hamilton, MT - Homeopath

Donna Lee D'antuono, RN is a Homeopath based in Hamilton, Montana. Donna Lee D'antuono is licensed to practice in * (Not Available) (license number ) and her current practice location is 516 Wapiti Loop, Hamilton, Montana. She can be reached at her office (for appointments etc.) via phone at (406) 375-9245.

NPI number for Donna Lee D'antuono is 1194222117 and her current mailing address is 516 Wapiti Loop, Hamilton, Montana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1194222117.

Contact Information

	Donna Lee D'antuono, RN
	516 Wapiti Loop, Hamilton, MT 59840-9605
	(406) 375-9245
	Not Available

Provider's Profile

Full Name	Donna Lee D'antuono
Gender	Female
Speciality	Homeopath
Location	516 Wapiti Loop, Hamilton, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1194222117
Provider Enumeration Date: 04/06/2018
Last Update Date: 04/06/2018

Medical Identifiers

Medical identifiers for Donna Lee D'antuono such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194222117	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	99492 (Montana)	Secondary
175L00000X	Homeopath	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Donna Lee D'antuono is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Donna Lee D'antuono, RN 516 Wapiti Loop, Hamilton, MT 59840-9605 Ph: (406) 375-9245	Donna Lee D'antuono, RN 516 Wapiti Loop, Hamilton, MT 59840-9605 Ph: (406) 375-9245

News Archive

TNF-alpha inhibitors and interleukin inhibitors to drive psoriasis drug market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors will drive the psoriasis drug market to increase from $3 billion in 2008 to $5.2 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Transient receptor potential channel A1 causes calcitonin gene-related peptide release in neurons

Transient receptor potential channel A1 is one of the important transducers of noxious stimuli in the primary afferents, which may contribute to generation of neurogenic inflammation and hyperalgesia.

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.

Financially weak hospitals continue to struggle, say health researchers

The recent economic recession affected hospitals across the nation, regardless of financial status, but following the rebound, financially weak and safety-net hospitals continue to struggle, according to health researchers.

Donna Lee D'antuono, RN - Homeopath in Hamilton, MT